Rochester, Minn.-based Mayo Clinic has entered into a multiyear partnership with U.K.-based company Oxford Nanopore to explore genetic predispositions to cancer.
Read the full post on Becker's Hospital Review - Healthcare News
Mayo Clinic to develop genetic cancer tests in new partnership
